MENU
+Compare
CNVVF
Stock ticker: OTC
AS OF
Nov 10 closing price
Price
$2.78
Change
-$0.33 (-10.61%)
Capitalization
6.13B

CNVVF ConvaTec Group plc Forecast, Technical & Fundamental Analysis

Originally spun out of Bristol-Myers Squibb, ConvaTec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings... Show more

CNVVF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for CNVVF with price predictions
Nov 12, 2025

CNVVF sees MACD Histogram crosses below signal line

CNVVF saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 10, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 23 instances where the indicator turned negative. In of the 23 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CNVVF as a result. In of 26 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 50-day moving average for CNVVF moved below the 200-day moving average on October 24, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

CNVVF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.021) is normal, around the industry mean (10.242). P/E Ratio (26.226) is within average values for comparable stocks, (158.743). Projected Growth (PEG Ratio) (1.409) is also within normal values, averaging (2.733). Dividend Yield (0.024) settles around the average of (0.016) among similar stocks. P/S Ratio (2.425) is also within normal values, averaging (111.072).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CNVVF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNVVF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
CNVVF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

CNVVF paid dividends on October 14, 2021

ConvaTec Group plc CNVVF Stock Dividends
А dividend of $0.02 per share was paid with a record date of October 14, 2021, and an ex-dividend date of September 02, 2021. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
20 Eastbourne Terrace
Phone
+44 7826447807
Employees
10129
Web
https://www.convatecgroup.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EHSTX27.810.20
+0.72%
Eaton Vance Large-Cap Value A
ANTMX12.080.07
+0.58%
American Century Intl Sm-Md Cp G
MECVX16.520.02
+0.12%
NYLI Epoch Capital Growth Investor Class
BALPX9.90N/A
N/A
BlackRock Event Driven Equity Inv A
CGFAX87.56-0.01
-0.01%
American Funds Growth Fund of Amer 529A

CNVVF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CNVVF has been loosely correlated with FLMNY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CNVVF jumps, then FLMNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNVVF
1D Price
Change %
CNVVF100%
N/A
FLMNY - CNVVF
36%
Loosely correlated
N/A
SAFLY - CNVVF
32%
Poorly correlated
N/A
GKOS - CNVVF
24%
Poorly correlated
+3.03%
EW - CNVVF
23%
Poorly correlated
+0.49%
OFIX - CNVVF
22%
Poorly correlated
-0.52%
More

Groups containing CNVVF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNVVF
1D Price
Change %
CNVVF100%
N/A
Pharmaceuticals
category (378 stocks)
0%
Poorly correlated
-0.99%
Pharmaceuticals: Other
category (103 stocks)
-0%
Poorly correlated
-1.40%